Genprex, Inc. — Form D
Genprex, Inc. of Austin, TX, a company, filed a Form D exempt-offering notice with the SEC on 2019-11-22. The offering totals $1.5M. Industry: Biotechnology.
Offering
- Filed: 2019-11-22
- Form: D
- Accession: 0001437749-19-023449
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.5M
- Remaining: $1.5M
- Investors: 2
- Date of first sale: 2019-11-22
- Revenue range: Decline to Disclose
- SEC file number: 021-354072
Issuer
- Name: Genprex, Inc.
- CIK: 0001595248
- Entity type: Corporation
- Jurisdiction: TEXAS
- Incorporated: 2009
- Address: 1601 Trinity Street, Bldg. B, Ste 3322, Austin, TX, 78712
- Phone: 512-370-4081
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| David E Friedman | Director | Boca Raton, FL |
| Robert W Pearson | Director | Austin, TX |
| John Rodney Varner | Director | Austin, TX |
| Ryan M Confer | Executive Officer | Austin, TX |
| Julien M Pham | Executive Officer | Austin, TX |
| John Rodney Varner | Executive Officer | Austin, TX |
| David Friedman | Director | NEW HAVEN, CT |
| Julien Rodney Pham | Executive Officer | Austin, TX |
| David Rodney Friedman | Director | Austin, TX |
| Robert Rodney Pearson | Director | Austin, TX |
| Ryan Rodney Confer | Executive Officer | Austin, TX |
| Bob Rodney Pearson | Director | Austin, TX |
| Bob Pearson | Director | Austin, TX |
Other filings by this issuer (6)
More